Bioblast Pharma Ltd. (ORPN) Climbed 24.63% or 0.33 To Price $1.67 On Thursday


Bioblast Pharma Ltd. (ORPN) climbed 24.63% or 0.33 to $1.67. It is around 566667 shares traded, which is 1122.78% compare to the average total volume 50470. The market cap of ORPN is $5.58 million. The year to date change is -15.01%. The 52 week price range is from $1.03 to $5.99. Price of ORPN have changed -6.94% during last week. It have changed 6.67% over last month, -21.64% over last 3 months, -32.32% over last 6 months and -38.25% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 1.24. It is -25.75% below current price. The 200-day Moving Averages for ORPN is 2.04. It is 22.16% above current price. The 52-week High is 5.99. It is 258.68% from the current price. The 52-week Low is 1.03. It is -38.32% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 6.07 on 2018-09-14. Short % to float is 5.01%. There are some statistics of ORPN. It is has market cap $5.58 million. The share outstanding is 3.34 million. The average volume is 50470. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -100.24%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -83.43%.


Tags:

Share this post